Silphium Asset Management LTD Obs Eva Sa Transaction History

Silphium Asset Management LTD

  • $280 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jan 30, 2025
SELL
$2.01 - $5.95 $382,314 - $1.13 Million
-190,206 Closed
0 $0
Q1 2020

Jan 30, 2025
BUY
$1.87 - $4.47 $229,015 - $547,431
122,468 Added 180.8%
190,206 $458 Million
Q3 2019

Jan 30, 2025
BUY
$8.22 - $11.2 $556,806 - $758,665
67,738 New
67,738 $564 Million

Others Institutions Holding OBSV

# of Institutions
2
Shares Held
88K
Call Options Held
0
Put Options Held
0
View Full List

About ObsEva SA

OBSV Quotes by TradingView
  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Silphium Asset Management LTD Portfolio

Follow Silphium Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silphium Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Silphium Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email